Suicide

OpenAI acknowledges ChatGPT's risks to psychiatric patients and commits to improving safety measures, but skepticism about their sincerity remains.

Explore the latest research on athlete mental health, highlighting concussion recovery, anti-doping stress, and the protective role of competitive sports.

AI chatbots pose significant mental health risks, often exacerbating issues like suicide, self-harm, and delusions, highlighting urgent regulatory needs.

NRx Pharmaceuticals secures FDA Fast Track designation for NRX-100, a preservation-free formulation of intravenous ketamine for suicidal ideation in depression.

Youth with neurodevelopmental disorders face significant suicide risks.

The debate over palliative psychiatry's role in advocating for psychiatric euthanasia continues, raising ethical concerns about mental health care and patient autonomy.

The complex ethics of dying, death, and assisted dying lead to debates on terminology and implications for patient autonomy and suffering.

Christine Yu Moutier, MD, the chief medical officer of the AFSP, speaks about the impact of losing LGBTQ+ tailored crisis support via 988, and strategies to better support vulnerable youth.

LGBTQ+ youth face increased suicide risks as vital support services are cut, prompting urgent calls for Congress to reverse this dangerous decision.

There is a critical link between sleep disorders and psychiatric conditions. In this Special Report, examine effective diagnosis and treatment strategies for better patient outcomes.

Effective safety plans are an important measure for suicide prevention. Emphasizing early intervention and structured support can reduce risks and save lives.

Euthanasia risks becoming a symptom of burnout.

Explore the ethical complexities of euthanasia and assisted suicide through a philosophical lens.

NRx Pharmaceuticals secures FDA fee waiver for NRX-100, a preservative-free ketamine aimed at treating suicidal depression, enhancing accessibility for patients.

“Call no man happy before he is dead.”

Exploring the complexities of assisted dying, ethical dilemmas, and the evolving role of physicians in end-of-life decisions.

The debate on physician-assisted suicide challenges medical ethics, emphasizing the role of doctors in providing care, not death, while navigating societal pressures.

A recent study reveals some alarming statistics about physician suicide. What interventions can help reduce this trend?

The Lancet Commission report on nonfatal self-harm identifies key challenges, causes, and more.

New research reveals that discontinuing long-term benzodiazepine therapy may increase risks of mortality and other adverse outcomes, challenging common assumptions.

Here are highlights from this week in Psychiatric Times, including updates on the BHV-7000 for bipolar disorder trial and a new study on physician suicide rates.

A new study found that suicidal ideation and firearm access are the strongest predictors of veteran suicide risk.

A recent study found that female physicians have a 53% higher risk of suicide compared with the female general population.

At least 300 to 400 physicians a year die by suicide in the United States. Learn more about the latest statistics.

Psychiatry may often encounter suicide and homicide, but what is its relationship with ecocide and genocide?

According to a new study, the launch of 988 did not equate to significant, equitable growth in availability of crisis services.

How can you manage health care coordination for patients who traverse various levels of care?

Extreme risk protection orders may be an effective suicide prevention tool.

Palliative psychiatry takes a dangerous turn when discussions lead to advocacy for assisted suicide policies for mental illness.

A systematic review and meta-analysis showed moderate-quality evidence supporting lithium’s ability to lower mortality rates.